Precision Revolution: $246.66 Billion Market to Transform Global Healthcare by 2029

The global Precision Diagnostics and Medicine market is set to reach a staggering $246.66 billion by 2029, growing at a robust CAGR of 11.1%. Driven by advancements in artificial intelligence, machine learning, and genomics, this industry is revolutionizing healthcare with personalized treatments for oncology, neurology, immunology, rare diseases, and infectious conditions.

Direct-to-consumer genetic testing and wearable medical devices are gaining traction as patients increasingly seek tailored healthcare solutions. Pharmaceutical and diagnostics companies are investing heavily in precision therapies, making breakthroughs in monoclonal antibodies (mAbs), cell and gene therapies (CGT), and inhibitors. Despite challenges like high costs and big data integration, the market promises transformative growth.

Source: Globe Newswire